The stock finally ended at Rs 360, up around 2.7%. Around 1,643 shares were traded on the BSE today.
_______________________________________________
(Updated at 1204 hrs)
Cadila Healthcare has gained following genaration of a new drug.
The stock opened at Rs 369, up 5% from the previous close. It touched a low of Rs 355 and is now at Rs 360, up 2.5%. The counter has seen a thin volume of 440 shares so far on the BSE.
According to a release issued by the company to the BSE yesterday, Zydus Cadila and Karo Bio of Sweden, had generated a series of dissociated non-steroidal glucocorticoid against lead compounds. Theses are as potent as conventional steroids but with a significantly reduced potential to cause side effects.
